SPECIAL NOTICE
A -- Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) - TA4
- Notice Date
- 6/11/2026 3:07:23 PM
- Notice Type
- Special Notice
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- DEF ADVANCED RESEARCH PROJECTS AGCY ARLINGTON VA 222032114 USA
- ZIP Code
- 222032114
- Solicitation Number
- DARPA-SN-26-91
- Response Due
- 6/29/2026 3:00:00 PM
- Archive Date
- 07/28/2026
- Point of Contact
- LCDR Robert Murray, Program Manager, DARPA/BTO
- E-Mail Address
-
RAPIID@darpa.mil
(RAPIID@darpa.mil)
- Description
- The Defense Advanced Research Projects Agency (DARPA) is seeking support for commercialization of technologies to be developed under the upcoming Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) program. The purpose of this announcement is to notify the community of the RAPIID commercialization goals, initiate dialogue to address program needs, and share the timetable for full proposal submission. This special notice is released under the current DARPA BTO Office Wide Broad Agency Announcement (BAA) HR001126S0003, titled �Biological Technologies.�
- Web Link
-
SAM.gov Permalink
(https://sam.gov/workspace/contract/opp/61a78b0d91244a65b239a1248a80e7af/view)
- Record
- SN07848655-F 20260613/260611230042 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |